Newly Diagnosed Archives

April 9, 2025

What Does it Mean to Be Immunocompromised?

Patients with CLL have a hard time fighting off infections and other diseases, because their immune system doesn’t function as well as a healthy person’s.

March 17, 2025

Measles Risk for CLL Patients

Vaccines help but CLL patients may need the extra protection of Pre-Exposure Prophylaxis (PrEP) in the form of COVID-19 antibodies for passive immunity.

February 3, 2025

Norovirus: Considerations for Those With CLL

CLL patients, with their impaired immunity, are not only at risk for respiratory infections but also serious and prolonged gut problems from norovirus.

January 22, 2025

Winter Viral Infection Risks for Patients with CLL

While respiratory infections, especially COVID-19, can occur any time of the year, there is typically an increase in prevalence during the winter months.

December 4, 2024

BeiGene and CLL Society Partner to Advance Test Before Treat™ Campaign, Promoting Biomarker Testing to Improve Patient Outcomes in CLL

BeiGene and CLL Society partnered on Test Before Treat, educating healthcare providers and CLL / SLL patients about the importance of biomarker testing.

October 23, 2024

Vitamin D Associated with Longer Treatment-Free Survival in Early CLL

Taking vitamin D supplements during “watch and wait” (a.k.a. active surveillance) was associated with longer treatment-free survival in early-stage CLL.

October 23, 2024

More Vitamin D in Early CLL Improves Treatment-Free Survival

Taking vitamin D during watch and wait extended treatment-free survival from 84 to 169 months in all chronic lymphocytic leukemia (CLL) patients.

October 23, 2024

How CLL Impacts the Immune System

While chronic lymphocytic leukemia (CLL) is a cancer of the B cells, it can affect the whole immune system. Patients with CLL are immunocompromised.

October 11, 2024

Increased Fatigue May Predict CLL Disease Progression

Based on outcomes reported by patients, increased fatigue may predict disease progression in relapsed CLL / SLL patients on ibrutinib or zanubrutinib.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Newly Diagnosed

What Does it Mean to Be Immunocompromised?

Measles Risk for CLL Patients

Norovirus: Considerations for Those With CLL

Winter Viral Infection Risks for Patients with CLL

BeiGene and CLL Society Partner to Advance Test Before Treat™ Campaign, Promoting Biomarker Testing to Improve Patient Outcomes in CLL

Vitamin D Associated with Longer Treatment-Free Survival in Early CLL

More Vitamin D in Early CLL Improves Treatment-Free Survival

How CLL Impacts the Immune System

Increased Fatigue May Predict CLL Disease Progression

CLL SOCIETY FAST FIND

QUICK LINKS

ABOUT CLL SOCIETY

CONTACT